0:00
2:57
Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. Show references: https://www.nejm.org/doi/full/10.1056/NEJMoa2107454
More episodes from "Neurology Minute"
Don't miss an episode of “Neurology Minute” and subscribe to it in the GetPodcast app.